+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Primary Inner Plastic Packaging Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6159003
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pharmaceutical Primary Inner Plastic Packaging: Executive Overview

Pharmaceutical primary inner plastic packaging includes plastic components that directly contact medicines, such as bottles, vials, ampoules, blister webs, tubes, closures, and related delivery-system parts. Its performance is closely tied to product protection, dose integrity, patient safety, regulatory compliance, and manufacturing efficiency. The sector is evolving as pharmaceutical formulations become more sensitive, biologic therapies expand, and sustainability expectations increasingly influence material and design decisions.

Regulatory, Sustainability, and Product-Complexity Shifts Reshape Packaging

The landscape is being transformed by stricter expectations for extractables and leachables control, container-closure integrity, traceability, child resistance, tamper evidence, and compatibility with sterile or highly sensitive formulations. Pharmaceutical manufacturers and packaging suppliers are also addressing recycled-content requirements, waste reduction, material minimization, and end-of-life limitations without compromising barrier performance or patient safety. Growth in biologics, specialty medicines, prefilled systems, and self-administration is encouraging greater use of high-performance polymers, engineered closures, and device-compatible formats.

Artificial Intelligence Improves Design, Quality, and Supply-Chain Decisions

Artificial intelligence is increasingly relevant across the packaging value chain, although adoption depends on validated data, process controls, and regulated change management. Machine-learning systems can support automated visual inspection, defect classification, predictive maintenance, process-parameter optimization, and early detection of contamination or dimensional variation. Generative design and digital simulation can help evaluate lightweighting, barrier requirements, ergonomics, and compatibility before tooling is finalized. In regulated environments, AI outputs require documented validation, human oversight, cybersecurity safeguards, and auditable decision trails.

Regional Dynamics Differ by Regulation, Manufacturing Depth, and Sustainability Pressure

North America combines stringent quality expectations with advanced pharmaceutical manufacturing, strong demand for sterile and specialty formats, and increasing attention to supply resilience. Latin America is shaped by expanding healthcare access, local production priorities, import dependencies, and uneven recycling infrastructure. Europe places particularly strong emphasis on circularity, chemical safety, traceability, and harmonized pharmaceutical compliance. The Middle East is developing pharmaceutical and packaging capabilities while prioritizing supply security and localization. Africa presents varied regulatory and infrastructure conditions, with needs centered on dependable protection, distribution durability, and affordable formats. Asia-Pacific combines major pharmaceutical production centers, rapid healthcare expansion, sophisticated contract manufacturing, and wide variation in regulatory maturity and sustainability infrastructure.

Economic and Strategic Groups Create Distinct Compliance and Supply Priorities

ASEAN markets require packaging strategies that accommodate diverse regulations, climates, healthcare systems, and manufacturing capabilities while supporting regional supply-chain integration. BRICS economies combine substantial pharmaceutical demand and production capacity with differing standards, localization policies, and recycling systems. The European Union emphasizes harmonized safety requirements, environmental performance, and product stewardship. G7 markets generally prioritize advanced quality systems, resilient sourcing, patient-centric design, and evidence-based sustainability. GCC countries emphasize reliable imports, pharmaceutical localization, and packaging suited to demanding heat and logistics conditions. NATO members span varied industrial bases but share heightened interest in critical-supply resilience, cybersecurity, and continuity of healthcare manufacturing.

Country Conditions Highlight Varied Opportunities for Compliance and Localization

Australia emphasizes stringent therapeutic-product controls, reliable distribution, and packaging suited to geographically dispersed healthcare delivery. Brazil combines a large pharmaceutical system with complex regulatory and localization considerations. Canada prioritizes quality, bilingual or accessibility-aware labeling contexts, and supply continuity. China is strengthening domestic pharmaceutical and packaging capabilities while maintaining rigorous expectations for product quality and traceability. France, Germany, Italy, and Spain operate within the European regulatory environment while retaining distinct industrial strengths and sustainability priorities. India combines large-scale medicine production, cost sensitivity, and expanding quality-system requirements. Japan emphasizes precision, reliability, aging-population needs, and highly controlled manufacturing. Mexico benefits from pharmaceutical manufacturing integration with North American supply chains while managing regulatory and logistics variation. Russia faces supply-chain, technology-access, and localization constraints that affect material and equipment choices. South Korea combines advanced manufacturing, biologics capability, and strong technology adoption. The United Kingdom maintains rigorous medicines regulation, sophisticated pharmaceutical production, and increasing interest in resilient and sustainable packaging. The United States places strong emphasis on container-closure performance, sterile manufacturing, inspection, traceability, and supply-chain security.

Industry Leaders Should Align Material Innovation With Validated Patient Safety

Leaders should establish a lifecycle-based packaging strategy that links formulation compatibility, barrier needs, sterilization, transport conditions, usability, and end-of-life considerations. They should qualify multiple sources for critical polymers, closures, and conversion processes; strengthen container-closure and extractables-and-leachables testing; and maintain clear change-control procedures. Sustainability programs should prioritize measurable material reduction, design for recovery where feasible, and evidence that environmental improvements do not weaken protection or compliance. Organizations should deploy AI first in bounded, auditable use cases such as inspection and predictive maintenance, supported by validated datasets and human review. Finally, regional teams should adapt designs to local regulations, climate, infrastructure, and patient-use conditions rather than relying on a single global format.

Research Methodology for the Pharmaceutical Primary Inner Plastic Packaging Review

This executive summary uses a structured secondary-research framework focused on pharmaceutical primary inner plastic packaging and its direct-contact applications. The assessment considers packaging formats, polymer performance, container-closure integrity, sterile and non-sterile use cases, regulatory requirements, sustainability pressures, pharmaceutical manufacturing trends, supply-chain resilience, and technology adoption. Regional, group, and country perspectives are synthesized from publicly available regulatory, industrial, scientific, and policy information. Findings are qualitative and directional; no market estimates, market sizing, market shares, or forecasts are presented.

Resilient, Compliant, and Sustainable Packaging Will Define Competitive Readiness

Pharmaceutical primary inner plastic packaging is becoming a strategic component of medicine quality rather than a purely functional input. Success will depend on balancing chemical and physical protection, manufacturability, patient usability, regulatory evidence, supply resilience, and environmental responsibility. Companies that combine disciplined qualification with targeted innovation, transparent data, and regionally informed execution will be better positioned to support increasingly complex pharmaceutical products and evolving healthcare expectations.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pharmaceutical Primary Inner Plastic Packaging Market, by Container Type
7.1. Introduction
7.2. Ampoules
7.3. Bottles
7.4. Cartridges
7.5. Syringes
7.6. Vials
8. Pharmaceutical Primary Inner Plastic Packaging Market, by Material Type
8.1. Introduction
8.2. High Density Polyethylene
8.3. Low Density Polyethylene
8.4. Polypropylene
8.5. Polyvinyl Chloride
9. Pharmaceutical Primary Inner Plastic Packaging Market, by Sterility
9.1. Introduction
9.2. Non Sterile
9.3. Sterile
10. Pharmaceutical Primary Inner Plastic Packaging Market, by Closure Mechanism
10.1. Introduction
10.2. Child Resistant Cap
10.3. Crimp Seal
10.4. Flip Top Cap
10.5. Screw Cap
11. Pharmaceutical Primary Inner Plastic Packaging Market, by Application
11.1. Introduction
11.2. Injectable
11.3. Oral
11.4. Topical
12. Pharmaceutical Primary Inner Plastic Packaging Market, by Manufacturing Technology
12.1. Introduction
12.2. Blow Molding
12.3. Extrusion Molding
12.4. Injection Molding
12.5. Thermoforming
13. Pharmaceutical Primary Inner Plastic Packaging Market, by End Use
13.1. Introduction
13.2. Hospitals
13.3. Laboratories
14. Pharmaceutical Primary Inner Plastic Packaging Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Pharmaceutical Primary Inner Plastic Packaging Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Pharmaceutical Primary Inner Plastic Packaging Market, by Country
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. ALPLA GmbH
18.2. Amcor PLC
18.3. AptarGroup, Inc.
18.4. Bormioli Pharma S.p.A.
18.5. Gerresheimer AG
18.6. MM Group
18.7. Nipro Corporation
18.8. Nolato AB (publ)
18.9. Plastipak Holding, Inc.
18.10. Shaily Engineering Plastics Ltd.
18.11. Silgan Holdings Inc.
18.12. Sonoco Products Company
18.13. West Pharmaceutical Services, Inc.
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Pharmaceutical Primary Inner Plastic Packaging Market, Years Considered for the Study
FIGURE 2. Global Pharmaceutical Primary Inner Plastic Packaging Market, Research Design
FIGURE 3. Global Pharmaceutical Primary Inner Plastic Packaging Market, Research Framework
FIGURE 4. Global Pharmaceutical Primary Inner Plastic Packaging Market, Data Triangulation
FIGURE 5. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2025 vs 2032 (%)
FIGURE 7. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2025 vs 2032 (%)
FIGURE 9. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2025 vs 2032 (%)
FIGURE 11. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2025 vs 2032 (%)
FIGURE 13. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2025 vs 2032 (%)
FIGURE 17. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2025 vs 2032 (%)
FIGURE 19. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Pharmaceutical Primary Inner Plastic Packaging Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Pharmaceutical Primary Inner Plastic Packaging Market Segmentation & Coverage
TABLE 2. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 4. Global Ampoules Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Ampoules Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Ampoules Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Bottles Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Cartridges Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Cartridges Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Cartridges Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 20. Global High Density Polyethylene Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global High Density Polyethylene Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global High Density Polyethylene Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Low Density Polyethylene Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Low Density Polyethylene Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Low Density Polyethylene Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Polypropylene Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Polypropylene Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Polypropylene Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Polyvinyl Chloride Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Polyvinyl Chloride Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Polyvinyl Chloride Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 33. Global Non Sterile Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Non Sterile Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Non Sterile Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Sterile Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Sterile Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Sterile Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 40. Global Child Resistant Cap Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Child Resistant Cap Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Child Resistant Cap Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Crimp Seal Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Crimp Seal Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Crimp Seal Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Flip Top Cap Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Flip Top Cap Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Flip Top Cap Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Screw Cap Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Screw Cap Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Screw Cap Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 53. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 63. Global Blow Molding Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Blow Molding Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Blow Molding Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Extrusion Molding Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Extrusion Molding Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Extrusion Molding Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Injection Molding Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Injection Molding Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Injection Molding Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Thermoforming Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Thermoforming Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Thermoforming Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 76. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Pharmaceutical Primary Inner Plastic Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 91. North America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. North America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 93. North America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 94. North America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 95. North America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 96. North America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. North America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 98. North America Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 99. Latin America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Latin America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 101. Latin America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 102. Latin America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 103. Latin America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 104. Latin America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Latin America Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 106. Latin America Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 107. Europe Pharmaceutical Primary Inner Plastic Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Europe Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 109. Europe Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 110. Europe Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 111. Europe Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 112. Europe Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Europe Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 114. Europe Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 115. Middle East Pharmaceutical Primary Inner Plastic Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Middle East Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 117. Middle East Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 118. Middle East Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 119. Middle East Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 120. Middle East Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Middle East Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 122. Middle East Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 123. Africa Pharmaceutical Primary Inner Plastic Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Africa Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 125. Africa Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 126. Africa Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 127. Africa Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 128. Africa Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. Africa Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 130. Africa Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 131. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. ASEAN Pharmaceutical Primary Inner Plastic Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. ASEAN Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 134. ASEAN Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 135. ASEAN Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 136. ASEAN Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 137. ASEAN Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. ASEAN Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 139. ASEAN Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 140. GCC Pharmaceutical Primary Inner Plastic Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. GCC Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 142. GCC Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 143. GCC Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 144. GCC Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 145. GCC Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. GCC Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 147. GCC Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 148. European Union Pharmaceutical Primary Inner Plastic Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. European Union Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 150. European Union Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 151. European Union Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 152. European Union Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 153. European Union Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. European Union Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 155. European Union Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 156. BRICS Pharmaceutical Primary Inner Plastic Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. BRICS Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 158. BRICS Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 159. BRICS Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 160. BRICS Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 161. BRICS Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. BRICS Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 163. BRICS Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 164. G7 Pharmaceutical Primary Inner Plastic Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. G7 Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 166. G7 Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 167. G7 Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 168. G7 Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 169. G7 Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. G7 Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 171. G7 Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 172. NATO Pharmaceutical Primary Inner Plastic Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. NATO Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 174. NATO Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 175. NATO Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 176. NATO Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 177. NATO Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. NATO Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 179. NATO Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 180. Global Pharmaceutical Primary Inner Plastic Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. United States Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 182. United States Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 183. United States Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 184. United States Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 185. United States Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 186. United States Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. United States Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 188. United States Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 189. Canada Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 190. Canada Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 191. Canada Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 192. Canada Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 193. Canada Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 194. Canada Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. Canada Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 196. Canada Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 197. Mexico Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 198. Mexico Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 199. Mexico Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 200. Mexico Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 201. Mexico Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 202. Mexico Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. Mexico Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 204. Mexico Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 205. Brazil Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 206. Brazil Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 207. Brazil Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 208. Brazil Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 209. Brazil Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 210. Brazil Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Brazil Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 212. Brazil Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 213. United Kingdom Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 214. United Kingdom Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 215. United Kingdom Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 216. United Kingdom Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 217. United Kingdom Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 218. United Kingdom Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. United Kingdom Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 220. United Kingdom Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 221. Germany Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 222. Germany Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 223. Germany Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 224. Germany Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 225. Germany Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 226. Germany Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Germany Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 228. Germany Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 229. France Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 230. France Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 231. France Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 232. France Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 233. France Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 234. France Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. France Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 236. France Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 237. Russia Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 238. Russia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 239. Russia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 240. Russia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 241. Russia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 242. Russia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. Russia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 244. Russia Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 245. Italy Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 246. Italy Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 247. Italy Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 248. Italy Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 249. Italy Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 250. Italy Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. Italy Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 252. Italy Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 253. Spain Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 254. Spain Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 255. Spain Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 256. Spain Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 257. Spain Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 258. Spain Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Spain Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 260. Spain Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 261. China Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 262. China Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 263. China Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 264. China Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 265. China Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 266. China Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. China Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 268. China Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 269. India Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 270. India Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 271. India Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 272. India Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 273. India Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 274. India Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. India Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 276. India Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 277. Japan Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 278. Japan Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 279. Japan Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 280. Japan Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 281. Japan Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 282. Japan Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. Japan Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 284. Japan Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 285. Australia Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 286. Australia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 287. Australia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 288. Australia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 289. Australia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 290. Australia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. Australia Pharmaceutical Primary Inner Plastic Packaging Market Size, by Manufacturing Technology, 2017-2032 (USD Million)
TABLE 292. Australia Pharmaceutical Primary Inner Plastic Packaging Market Size, by End Use, 2017-2032 (USD Million)
TABLE 293. South Korea Pharmaceutical Primary Inner Plastic Packaging Market Size, 2017-2032 (USD Million)
TABLE 294. South Korea Pharmaceutical Primary Inner Plastic Packaging Market Size, by Container Type, 2017-2032 (USD Million)
TABLE 295. South Korea Pharmaceutical Primary Inner Plastic Packaging Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 296. South Korea Pharmaceutical Primary Inner Plastic Packaging Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 297. South Korea Pharmaceutical Primary Inner Plastic Packaging Market Size, by Closure Mechanism, 2017-2032 (USD Million)
TABLE 298. South Korea Pharmaceutical Primary Inner Plastic Packaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. South Korea Pharmaceutical Primary Inner Plastic Packag

Companies Mentioned

  • ALPLA GmbH
  • Amcor PLC
  • AptarGroup, Inc.
  • Bormioli Pharma S.p.A.
  • Gerresheimer AG
  • MM Group
  • Nipro Corporation
  • Nolato AB (publ)
  • Plastipak Holding, Inc.
  • Shaily Engineering Plastics Ltd.
  • Silgan Holdings Inc.
  • Sonoco Products Company
  • West Pharmaceutical Services, Inc.